Atara Biotherapeutics, Inc.
ATRANasdaqCIK 1604464HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | 2.1Revenue, Q3 FY2023, three months to 2023-09-30$2.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 4.3Revenue, Q4 FY2023, three months to 2023-12-31$4.3m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | 27.4Revenue, Q1 FY2024, three months to 2024-03-31$27.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 28.6Revenue, Q2 FY2024, three months to 2024-06-30$28.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 40.2Revenue, Q3 FY2024, three months to 2024-09-30$40.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 32.8Revenue, Q4 FY2024, three months to 2024-12-31$32.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 98.1Revenue, Q1 FY2025, three months to 2025-03-31$98.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 17.6Revenue, Q2 FY2025, three months to 2025-06-30$17.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 3.5Revenue, Q3 FY2025, three months to 2025-09-30$3.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 1.6Revenue, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 0.5Revenue, Q1 FY2026, three months to 2026-03-31$516.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 0.6Revenue, Q2 FY2026, three months to 2026-06-30$630.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Research and development | $m | 56.9Research and development, Q3 FY2023, three months to 2023-09-30$56.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 49.6Research and development, Q4 FY2023, three months to 2023-12-31$49.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | 45.5Research and development, Q1 FY2024, three months to 2024-03-31$45.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 33.3Research and development, Q2 FY2024, three months to 2024-06-30$33.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 43.9Research and development, Q3 FY2024, three months to 2024-09-30$43.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 28.7Research and development, Q4 FY2024, three months to 2024-12-31$28.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 27.4Research and development, Q1 FY2025, three months to 2025-03-31$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 7.3Research and development, Q2 FY2025, three months to 2025-06-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 2.9Research and development, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (0.2)Research and development, Q4 FY2025, three months to 2025-12-31−$223.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 0.2Research and development, Q1 FY2026, three months to 2026-03-31$164.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 1.3Research and development, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Operating income | $m | (69.6)Operating income, Q3 FY2023, three months to 2023-09-30−$69.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | (60.0)Operating income, Q4 FY2023, three months to 2023-12-31−$60.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | (31.2)Operating income, Q1 FY2024, three months to 2024-03-31−$31.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | (18.2)Operating income, Q2 FY2024, three months to 2024-06-30−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | (21.8)Operating income, Q3 FY2024, three months to 2024-09-30−$21.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (12.2)Operating income, Q4 FY2024, three months to 2024-12-31−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 38.8Operating income, Q1 FY2025, three months to 2025-03-31$38.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 3.2Operating income, Q2 FY2025, three months to 2025-06-30$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (3.6)Operating income, Q3 FY2025, three months to 2025-09-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (2.6)Operating income, Q4 FY2025, three months to 2025-12-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | (3.4)Operating income, Q1 FY2026, three months to 2026-03-31−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | (4.7)Operating income, Q2 FY2026, three months to 2026-06-30−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Interest expense | $m | 1.4Interest expense, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 1.2Interest expense, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | 1.2Interest expense, Q1 FY2024, three months to 2024-03-31$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 1.3Interest expense, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 1.2Interest expense, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 1.0Interest expense, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 1.0Interest expense, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 1.0Interest expense, Q2 FY2025, three months to 2025-06-30$972.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 0.9Interest expense, Q3 FY2025, three months to 2025-09-30$909.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 0.9Interest expense, Q4 FY2025, three months to 2025-12-31$894.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 0.8Interest expense, Q1 FY2026, three months to 2026-03-31$830.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 0.2Interest expense, Q2 FY2026, three months to 2026-06-30$191.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Income tax | $m | (0.0)Income tax, Q3 FY2023, three months to 2023-09-30−$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 0.0Income tax, Q4 FY2023, three months to 2023-12-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2024, three months to 2024-03-31$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | (0.0)Income tax, Q3 FY2024, three months to 2024-09-30−$17.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 0.0Income tax, Q2 FY2025, three months to 2025-06-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 0.0Income tax, Q3 FY2025, three months to 2025-09-30$28.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 0.0Income tax, Q2 FY2026, three months to 2026-06-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Net income | $m | (69.8)Net income, Q3 FY2023, three months to 2023-09-30−$69.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | (60.5)Net income, Q4 FY2023, three months to 2023-12-31−$60.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | (31.8)Net income, Q1 FY2024, three months to 2024-03-31−$31.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (19.0)Net income, Q2 FY2024, three months to 2024-06-30−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (21.9)Net income, Q3 FY2024, three months to 2024-09-30−$21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (12.7)Net income, Q4 FY2024, three months to 2024-12-31−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 38.0Net income, Q1 FY2025, three months to 2025-03-31$38.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 2.4Net income, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (4.3)Net income, Q3 FY2025, three months to 2025-09-30−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (3.4)Net income, Q4 FY2025, three months to 2025-12-31−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | (4.1)Net income, Q1 FY2026, three months to 2026-03-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (4.8)Net income, Q2 FY2026, three months to 2026-06-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Diluted EPS | $ per share | (16.40)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$16.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | not reported | (5.65)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$5.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | (3.10)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$3.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | (2.93)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | not reported | 3.50Diluted EPS, Q1 FY2025, three months to 2025-03-31$3.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 0.19Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (0.32)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | not reported | (0.29)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | (0.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Basic EPS | $ per share | (16.40)Basic EPS, Q3 FY2023, three months to 2023-09-30−$16.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | not reported | (5.65)Basic EPS, Q1 FY2024, three months to 2024-03-31−$5.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | (3.10)Basic EPS, Q2 FY2024, three months to 2024-06-30−$3.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | (2.93)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | not reported | 3.53Basic EPS, Q1 FY2025, three months to 2025-03-31$3.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 0.20Basic EPS, Q2 FY2025, three months to 2025-06-30$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (0.32)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | not reported | (0.29)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | (0.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 64.8Cash and equivalents, Q3 FY2023, at 2023-09-30$64.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-01, accession 0000950170-23-057147.Report this figure | 25.8Cash and equivalents, FY2023, at 2023-12-31$25.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-07, accession 0000950170-25-035507.Report this figure | 35.1Cash and equivalents, Q1 FY2024, at 2024-03-31$35.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-056959.Report this figure | 31.3Cash and equivalents, Q2 FY2024, at 2024-06-30$31.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0000950170-24-095533.Report this figure | 46.5Cash and equivalents, Q3 FY2024, at 2024-09-30$46.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 25.0Cash and equivalents, FY2024, at 2024-12-31$25.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001193125-26-108361.Report this figure | 13.8Cash and equivalents, Q1 FY2025, at 2025-03-31$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 16.9Cash and equivalents, Q2 FY2025, at 2025-06-30$16.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 5.7Cash and equivalents, Q3 FY2025, at 2025-09-30$5.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 8.5Cash and equivalents, FY2025, at 2025-12-31$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 8.4Cash and equivalents, Q1 FY2026, at 2026-03-31$8.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 3.2Cash and equivalents, Q2 FY2026, at 2026-06-30$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Current assets | $m | 119Current assets, Q3 FY2023, at 2023-09-30$118.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0000950170-23-057147.Report this figure | 102Current assets, FY2023, at 2023-12-31$101.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-07, accession 0000950170-25-035507.Report this figure | 106Current assets, Q1 FY2024, at 2024-03-31$106.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056959.Report this figure | 62.4Current assets, Q2 FY2024, at 2024-06-30$62.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095533.Report this figure | 91.9Current assets, Q3 FY2024, at 2024-09-30$91.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 64.9Current assets, FY2024, at 2024-12-31$64.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108361.Report this figure | 27.2Current assets, Q1 FY2025, at 2025-03-31$27.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 24.8Current assets, Q2 FY2025, at 2025-06-30$24.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 18.4Current assets, Q3 FY2025, at 2025-09-30$18.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 12.2Current assets, FY2025, at 2025-12-31$12.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 12.2Current assets, Q1 FY2026, at 2026-03-31$12.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 13.5Current assets, Q2 FY2026, at 2026-06-30$13.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Total assets | $m | 189Total assets, Q3 FY2023, at 2023-09-30$188.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0000950170-23-057147.Report this figure | 166Total assets, FY2023, at 2023-12-31$165.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-07, accession 0000950170-25-035507.Report this figure | 165Total assets, Q1 FY2024, at 2024-03-31$165.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056959.Report this figure | 117Total assets, Q2 FY2024, at 2024-06-30$117.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095533.Report this figure | 143Total assets, Q3 FY2024, at 2024-09-30$142.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 109Total assets, FY2024, at 2024-12-31$109.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001193125-26-108361.Report this figure | 62.0Total assets, Q1 FY2025, at 2025-03-31$62.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 36.9Total assets, Q2 FY2025, at 2025-06-30$36.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 30.2Total assets, Q3 FY2025, at 2025-09-30$30.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 20.2Total assets, FY2025, at 2025-12-31$20.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 20.0Total assets, Q1 FY2026, at 2026-03-31$20.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 21.0Total assets, Q2 FY2026, at 2026-06-30$21.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Current liabilities | $m | 79.1Current liabilities, Q3 FY2023, at 2023-09-30$79.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0000950170-23-057147.Report this figure | 142Current liabilities, FY2023, at 2023-12-31$142.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-07, accession 0000950170-25-035507.Report this figure | 181Current liabilities, Q1 FY2024, at 2024-03-31$180.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056959.Report this figure | 148Current liabilities, Q2 FY2024, at 2024-06-30$148.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095533.Report this figure | 156Current liabilities, Q3 FY2024, at 2024-09-30$156.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 135Current liabilities, FY2024, at 2024-12-31$134.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108361.Report this figure | 47.9Current liabilities, Q1 FY2025, at 2025-03-31$47.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 14.6Current liabilities, Q2 FY2025, at 2025-06-30$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 18.1Current liabilities, Q3 FY2025, at 2025-09-30$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 14.9Current liabilities, FY2025, at 2025-12-31$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 5.6Current liabilities, Q1 FY2026, at 2026-03-31$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 6.8Current liabilities, Q2 FY2026, at 2026-06-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Total liabilities | $m | 240Total liabilities, Q3 FY2023, at 2023-09-30$239.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-01, accession 0000950170-23-057147.Report this figure | 265Total liabilities, FY2023, at 2023-12-31$264.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-07, accession 0000950170-25-035507.Report this figure | 264Total liabilities, Q1 FY2024, at 2024-03-31$263.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056959.Report this figure | 228Total liabilities, Q2 FY2024, at 2024-06-30$228.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095533.Report this figure | 233Total liabilities, Q3 FY2024, at 2024-09-30$233.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 206Total liabilities, FY2024, at 2024-12-31$206.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001193125-26-108361.Report this figure | 117Total liabilities, Q1 FY2025, at 2025-03-31$117.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 71.9Total liabilities, Q2 FY2025, at 2025-06-30$71.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0000950170-25-106550.Report this figure | 66.8Total liabilities, Q3 FY2025, at 2025-09-30$66.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | 58.7Total liabilities, FY2025, at 2025-12-31$58.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | 57.3Total liabilities, Q1 FY2026, at 2026-03-31$57.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | 58.0Total liabilities, Q2 FY2026, at 2026-06-30$58.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
| Shareholders' equity | $m | (50.8)Shareholders' equity, Q3 FY2023, at 2023-09-30−$50.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125389.Report this figure | 99.2Shareholders' equity, FY2023, at 2023-12-31$99.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001193125-26-108361.Report this figure | (98.3)Shareholders' equity, Q1 FY2024, at 2024-03-31−$98.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (111)Shareholders' equity, Q2 FY2024, at 2024-06-30−$110.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (90.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$90.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (97.3)Shareholders' equity, FY2024, at 2024-12-31−$97.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (55.1)Shareholders' equity, Q1 FY2025, at 2025-03-31−$55.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (35.0)Shareholders' equity, Q2 FY2025, at 2025-06-30−$35.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (36.6)Shareholders' equity, Q3 FY2025, at 2025-09-30−$36.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276219.Report this figure | (38.5)Shareholders' equity, FY2025, at 2025-12-31−$38.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (37.3)Shareholders' equity, Q1 FY2026, at 2026-03-31−$37.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure | (37.0)Shareholders' equity, Q2 FY2026, at 2026-06-30−$37.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346885.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (51.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$51.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125389. Derived: 9-month figure less the 6-month figure.Report this figure | (50.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$50.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | (29.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$29.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | (10.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0000950170-25-106550. Derived: 6-month figure less the 3-month figure.Report this figure | (4.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276219. Derived: 9-month figure less the 6-month figure.Report this figure | (24.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$24.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | (28.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$28.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | (7.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346885. Derived: 6-month figure less the 3-month figure.Report this figure | (9.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276219. Derived: 9-month figure less the 6-month figure.Report this figure | (5.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | (3.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219482.Report this figure | (3.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346885. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | 0.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$281.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125389. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-07, accession 0000950170-25-035507. Derived: 12-month figure less the 9-month figure.Report this figure | 0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$127.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106550. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276219. Derived: 9-month figure less the 6-month figure.Report this figure | 0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-072040.Report this figure | 0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0000950170-25-106550. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276219. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108361. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported |
Shares
| Line item | Unit | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 102 | 104 | 4.2 | 4.3 | 5.6 | 6.1 | 7.5 | 10.9 | 12.3 | 13.6 | 14.1 | 15.0 |
Shares outstanding: 10.04m at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.